Buy Isotroin

Isotroin

What is Isotroin?

Isotroin is a prescription medication that contains isotretinoin as its active ingredient. It is available in pill form in strengths of 10 mg and 20 mg. Isotretinoin belongs to the skin-care therapeutic class of retinoids and is primarily used for severe acne that has not responded to other treatments. In Hong Kong, Isotroin is regulated by the Hong Kong Department of Health - Drug Office and is only dispensed with a physician’s prescription.

How Isotroin Works in the Body

Isotretinoin is a synthetic derivative of vitamin A. It works by:

• Reducing the size and activity of sebaceous glands, leading to lower sebum production.
• Normalising follicular keratinisation, which prevents the formation of clogged pores.
• Exerting anti-inflammatory effects that lessen the redness and swelling associated with acne lesions.
• Binding to retinoic-acid receptors (RARs) in skin cells, which alters gene expression and promotes normal skin cell turnover.

These actions together address the three main pathogenic factors of severe acne: excess oil, abnormal shedding of skin cells, and inflammation. The medication begins to show visible improvement within several weeks, with peak benefit typically reached after 4-6 months of continuous therapy.

Conditions Treated by Isotroin

Isotretinoin is approved by health authorities in Hong Kong for the treatment of severe nodulocystic acne that is resistant to conventional oral antibiotics and topical therapies. It may also be prescribed for other serious dermatologic conditions when a dermatologist determines that the benefits outweigh the risks, but such uses are considered off-label.

Patient Suitability and Contraindications

Who Should Use Isotroin?

• Individuals with severe, recalcitrant acne who have not improved with standard treatments.
• Patients who are able to commit to regular laboratory monitoring and strict pregnancy-prevention measures.

Absolute Contraindications

• Pregnancy or planned pregnancy - isotretinoin is highly teratogenic.
• Known hypersensitivity to isotretinoin or any component of the tablet.
• Severe hepatic impairment or uncontrolled hyperlipidaemia.
• Concurrent use of tetracycline antibiotics (except minocycline) due to risk of intracranial hypertension.

Relative Contraindications / Special Populations

• Women of child-bearing potential must use two reliable forms of contraception and undergo monthly pregnancy testing.
• Patients with a history of depression or psychiatric disorders should be monitored closely.
• Elderly patients may require dose adjustments if renal or hepatic function is reduced.
• Pediatric use is generally reserved for adolescents with severe acne who meet weight-based dosing criteria.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Dry skin, lips (cheilitis), and mucous membranes - often the first sign of treatment.
• Mild itching or burning sensation.
• Temporary worsening of acne during the initial weeks (sometimes called “purging”).

Serious Adverse Events

• Teratogenicity - birth defects if exposure occurs during pregnancy.
• Elevated liver enzymes and triglyceride levels; regular blood tests are required.
• Pseudotumor cerebri - severe headache, visual disturbances, and papilledema.
• Mood changes, depression, or rare suicidal ideation.
• Severe skin reactions such as Stevens-Johnson syndrome (very rare).

Drug Interactions

• Vitamin A supplements - additive toxicity; avoid concurrent use.
• Tetracycline antibiotics (e.g., doxycycline) - increased risk of intracranial hypertension.
• Hormonal contraceptives - isotretinoin may reduce effectiveness; dual non-hormonal methods are recommended.
• Azithromycin - may also increase risk of intracranial hypertension.
• Systemic retinoids - concurrent use is contraindicated due to overlapping toxicity.

Food and Lifestyle Interactions

• Take the tablet with a full meal to improve absorption.
• Limit excessive alcohol intake because of potential liver strain.
• Sun protection is advisable; isotretinoin can increase skin photosensitivity.
• Driving and operating heavy machinery are generally safe, but severe dizziness should be reported promptly.

Dosing and Administration Guidelines

• Standard regimen: Isotretinoin is usually initiated at 0.5 mg/kg/day, adjusting up to 1 mg/kg/day based on clinical response and tolerance. The exact dose is selected from the available 10 mg or 20 mg tablets.
• Cumulative dosing: Treatment courses aim for a total cumulative dose of 120-150 mg/kg to reduce relapse risk.
• Frequency: The medication is taken once daily with food.
• Missed dose: Skip the missed tablet and resume the regular schedule; do not double the next dose.
• Overdose: Symptoms may include severe headache, visual changes, marked skin dryness, and nausea. Seek emergency medical care; supportive care is the mainstay of treatment.
• Discontinuation: No formal taper is required, but abrupt cessation should be discussed with a dermatologist to plan follow-up care.

Note: Dosing must be individualised by a qualified healthcare provider who considers body weight, severity of acne, and laboratory results.

Monitoring and Follow-Up

• Baseline and monthly laboratory tests: liver function tests (ALT, AST), fasting lipid profile, and pregnancy test for women of child-bearing potential.
• Clinical review: dermatologic assessment every 4-6 weeks to evaluate response and side-effect burden.
• Pregnancy testing: mandatory before initiation, then monthly throughout therapy and for one month after discontinuation.
• Psychiatric monitoring: report any new or worsening mood symptoms promptly.

Storage and Handling

• Store tablets at room temperature (below 30 °C), away from direct sunlight, moisture, and heat.
• Keep the medication out of reach of children; use child-proof containers.
• Do not use tablets after the expiration date printed on the package.
• Dispose of unused medication according to local pharmacy-take-back programs or Hong Kong’s waste-disposal guidelines.

Medication-Specific Glossary

Cumulative Dose

The total amount of isotretinoin taken over the entire treatment course, expressed in milligrams per kilogram of body weight.

Teratogenic

Capable of causing fetal malformations when exposure occurs during pregnancy.

Pseudotumor Cerebri

A condition characterised by increased intracranial pressure without an underlying mass, presenting with headache and visual changes.

Retinoic-Acid Receptor (RAR)

A nuclear receptor that mediates the biological actions of vitamin A derivatives, influencing gene transcription in skin cells.

Medical Disclaimer

This article provides educational information about Isotroin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.